GlaxoSmithKline: Funding Open Innovation
The 4-Traders website reported that GlaxoSmithKline (GSK) has announced a funding injection of up to £5m from the Wellcome Trust to support its open approach to discovering and developing urgently needed new treatments for diseases of the developing world. The funding will move early-stage research to the next level, to find new medicines for diseases such as TB, malaria, Leishmaniasis and sleeping sickness.
Click here to read the full article.